Volatility rose as global stocks and bonds whipsawed over the fortnight. Initially stocks dropped steeply when the CEO of Moderna said that existing vaccines would be much [...]

The US administration indicated it would support a suspension of intellectual property rights for Covid-19 vaccines. Such a suspension would allow any pharmaceutical [...]

There was further good news on the vaccine front, with Moderna reporting almost 95% efficacy for its vaccine. However, stock market gains were limited by signs that the [...]